Back/Palisade Bio Supports Allergy & Asthma Network’s New Patient Advocacy Leadership Initiative (PALI)
healthcare·January 16, 2026·pali

Palisade Bio Supports Allergy & Asthma Network’s New Patient Advocacy Leadership Initiative (PALI)

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • The Allergy & Asthma Network's PALI initiative empowers over 100 million Americans to advocate for better healthcare access.
  • PALI trains patients and caregivers on advocacy, legislative processes, and engaging with policymakers for meaningful change.
  • The initiative aims to amplify patient voices in shaping healthcare policies for improved access and quality of care.

Empowering Patient Advocacy: Allergy & Asthma Network Launches PALI Initiative

The Allergy & Asthma Network has unveiled the Patient Advocacy Leadership Initiative (PALI) to empower over 100 million Americans suffering from asthma, allergies, and related conditions. This ambitious initiative aims to train patients, caregivers, and families to become effective advocates in healthcare policy, addressing the persistent challenges they face in accessing necessary medications and care. According to CEO Lynda Mitchell, PALI signifies a strategic investment in cultivating a robust advocacy community capable of influencing health policies that prioritize the needs of those affected by these conditions.

PALI offers participants extensive training on the legislative process, advocacy messaging, and engaging with policymakers. Notably, this includes opportunities to attend the Allergy & Asthma Day Capitol Hill (AADCH), where advocates can directly connect with lawmakers. The initiative builds on the Allergy & Asthma Network’s 40-year history of advocacy, during which it has successfully collaborated with various stakeholders to promote policies that enhance treatment access and support research funding. This new program is a natural extension of the organization’s commitment to improving the lives of individuals with asthma and allergies.

As healthcare policy continues to evolve, PALI addresses the urgent need for informed advocates capable of driving meaningful change within the healthcare system. Director of Advocacy Nissa Shaffi emphasizes that patients and caregivers have invaluable insights into the daily realities of living with asthma and allergies. By equipping them with the necessary tools to articulate their experiences, PALI seeks to create a network of patient champions who can ensure that healthcare policies reflect the genuine challenges faced by affected communities. The ultimate vision is a future where the voices of those directly impacted shape healthcare policies, enhancing both access and quality of care.

In addition to the launch of PALI, the Allergy & Asthma Network emphasizes the importance of collaboration in advocating for improved healthcare access. The initiative not only focuses on individual empowerment but also aims to build a collective voice that resonates across various levels of government. By harnessing the experiences of patients and their families, PALI strives to create a more responsive healthcare environment that acknowledges and addresses the unique needs of individuals living with asthma and allergies.

The launch of PALI represents a pivotal moment for the Allergy & Asthma Network and the broader community of individuals affected by these conditions. As the initiative unfolds, it promises to strengthen the advocacy landscape, ensuring that patient experiences drive policy changes that ultimately enhance care access and quality for millions of Americans.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...